DME Capital Management »

Gain Therapeutics shares owned by DME Capital Management

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by DME Capital Management from 13F filings

Historical chart of DME Capital Management investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by DME Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by DME Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0M 566k 1.78
2024-06-30 $725k 566k 1.28
2024-03-31 $2.1M 566k 3.77